That was the road block. Now to see if the sellers reload or not. If this starts tightening up and the results warrant the value the price should rerate once more. Esh
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025